Celestone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosyovitis

Inclusion Criteria:

- Diagnosis of deQuervain tendinopathy

- Understands the local language and is willing and able to follow the requirements of
the protocol

- Understands the informed consent and signs the institutional review board/independent
ethics committee (IRB/IEC) approved informed consent form

Exclusion Criteria:

- Patients who have an allergy to lidocaine, celestone, or ketorolac, NSAIDS, or ASA

- Patients who have an adverse reaction to lidocaine, celestone, or ketorolac (such as
severe elevation of blood sugars in diabetics that caused medical complication)

- Patients who have received a prior steriod injection within the past three months

- Patients who have had a prior ipsilateral surgery for De!uervains Tenosyovitis

- Patients that have a skin lesion at the location of injection (such as trauma, eczema,
rash)

- Patients who have a current infection at the location of injection

- Patients who have had iontophoresis within three months

- Patients who are breast feeding, pregnant, or who plan to become pregnant in the next
six months